secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2023-01-17T23:59:59+00:00
Accession:  0001213900-23-002936
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Blue Water Vaccines appoints Timothy Ramdeen to board; Kimberly Murphy resigns
------------------------------------------------------------------------------

- Kimberly Murphy resigned from Board, Nominating, Compensation, and Audit Committees effective Jan 13, 2023; no disagreement with company.
- Board appointed Tim Ramdeen, founder/managing partner of Dharma Capital Advisors, to replace Murphy.
- Ramdeen will chair Nominating Committee and serve on Compensation and Audit Committees.
- Ramdeen brings nearly a decade of private equity and hedge fund investing experience, including at Altium Capital and Sixth Borough Capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390023002936/0001213900-23-002936-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390023002936/ea171727-8k_bluewater.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-002936

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer